Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 3 5Phase 4 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

Capecitabine 3Radiotherapy 2Oxaliplatin 2Fentanyl 2Bupivacaine 2udenafil 1sodium phosphate 1oxycodone-acetaminophen 1XELOX 1Tramadol 1Sildenafil Citrate 1Sevoflurane 1Propofol 1Pico-Salax 1Orphenadrine 1Neuroleptanalgesia 1Morphine 1Methadone 1Lidocaine 1Leucovorin 1Ketorolac Tromethamine 1Ketorolac 1Ketamine 1Irinotecan 1Hydromorphone 1Hydrocodone 1Gabapentin 1Fluorouracil 1Ertapenem 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Rectal Neoplasms × XELOX × Clear all
NCT04747951 2021-02-15

Total Neoadjuvant Therapy in Rectal Cancer Treatment

State Scientific Centre of Coloproctology, Russian Federation

Phase 4 Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡